Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.38 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.38 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.38 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.38 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.38 |
| ▸ | NAAA | Q02083 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.37 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29165486 | 0.98 | NR1I2 (0.43) | SIGMAR1NR1I2HTR2AOPRM1OPRD1 | |
| SCHEMBL15563133 | 0.98 | NR1I2 (0.43) | SIGMAR1NR1I2HTR2AOPRM1OPRD1 | |
| SCHEMBL10597887 | 0.95 | NR1I2 (0.43) | SIGMAR1NR1I2HTR2AOPRM1OPRD1 | |
| SCHEMBL5933904 | 0.95 | NR1I2 (0.43) | SIGMAR1NR1I2HTR2AOPRM1OPRD1 | |
| SCHEMBL10978603 | 0.95 | NR1I2 (0.43) | SIGMAR1NR1I2HTR2AOPRM1OPRD1 | |
| SCHEMBL15563156 | 0.94 | POLB (0.41) | SIGMAR1HTR2AOPRM1OPRD1OPRK1 | |
| SCHEMBL15563657 | 0.93 | SIGMAR1 (0.41) | SIGMAR1NR1I2HTR2AOPRM1OPRD1 | |
| SCHEMBL3680840 | 0.93 | POLB (0.41) | SIGMAR1NR1I2HTR2AOPRM1OPRD1 | |
| SCHEMBL16010374 | 0.91 | NR1I2 (0.43) | SIGMAR1NR1I2HTR2AOPRM1OPRD1 | |
| SCHEMBL7262623 | 0.91 | NR1I2 (0.43) | SIGMAR1NR1I2HTR2AOPRM1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11152208-B2 | Semiconductor film, method of forming semiconductor film, complex compound for doping, and method of doping | FLOSFIA INC. (JP) | 2021-10-19 | — | — | US | disclosed |
| US-11066431-B2 | Complex and method for producing same | KYOTO UNIVERSITY (JP) | 2021-07-20 | — | — | US | disclosed |
| WO-2021107870-A1 | ANTIMICROBIAL AGENT, COATING FORMULATION, COMPOSITE SURFACE COATING AND METHODS OF PREPARING THE SAME | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2021-06-03 | — | — | WO | disclosed |
| US-11015010-B2 | Block copolymer comprising catechol segment and inorganic nanoparticles coated by said block copolymer, as well as method for producing block copolymer comprising catechol segment and method for producing inorganic nanoparticles coated by said block copolymer | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2021-05-25 | — | — | US | disclosed |
| CN-108474115-B | Film forming method | 株式会社FLOSFIA | 2021-04-23 | — | — | CN | disclosed |
| US-10937972-B2 | Complex and perovskite material, and perovskite-type solar cell using complex or perovskite material | KYOTO UNIVERSITY (JP) | 2021-03-02 | — | — | US | disclosed |
| US-20210013035-A1 | SEMICONDUCTOR FILM, METHOD OF FORMING SEMICONDUCTOR FILM, COMPLEX COMPOUND FOR DOPING, AND METHOD OF DOPING | FLOSFIA INC. (JP) | 2021-01-14 | — | — | US | disclosed |
| CN-112106219-A | Method for manufacturing tin-based perovskite layer and solar cell | 国立大学法人京都大学 | 2020-12-18 | — | — | CN | disclosed |
| US-10851237-B2 | Block copolymer, multilayered structure, solid polymer membrane, fuel cell, method for producing multilayered structure, and method for producing multilayered structure including inorganic nanoparticles | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2020-12-01 | — | — | US | disclosed |
| US-20200332133-A1 | SOLVENT AND METHOD OF FORMING ORGANIC FILM USING SOLVENT | FLOSFIA INC (JP) | 2020-10-22 | — | — | US | disclosed |
| US-20170008993-A1 | BLOCK COPOLYMER COMPRISING CATECHOL ,SEGMENT AND INORGANIC NANOPARTICLES COATED BY SAID BLOCK COPOLYMER, AS WELL AS METHOD FOR PRODUCING BLOCK COPOLYMER COMPRISING CATECHOL, SEGMENT AND METHOD FOR PRODUCING INORGANIC NANOPARTICLES COATED BY SAID BLOCK COPOLYMER | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2017-01-12 | — | — | US | disclosed |
| EP-3112387-A1 | BLOCK COPOLYMER CONTAINING CATECHOL SEGMENT, INORGANIC NANOPARTICLES COATED BY SAID BLOCK COPOLYMER, METHOD FOR PRODUCING BLOCK COPOLYMER CONTAINING CATECHOL SEGMENT, AND METHOD FOR PRODUCING INORGANIC NANOPARTICLES COATED BY SAID BLOCK COPOLYMER | Japan Science and Technology Agency (JP) | 2017-01-04 | — | — | EP | disclosed |
| US-9493424-B2 | Antifungal compound | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2016-11-15 | — | — | US | disclosed |
| EP-3066065-A1 | CATALYTIC HYDROGENATION FOR PRODUCING AMINES FROM CARBOXYLIC ACID AMIDES, CARBOXYLIC ACID DIAMIDES, DI-, TRI-, OR POLYPEPETIDES, OR PEPTIDE AMIDES | Evonik Degussa GmbH (DE) | 2016-09-14 | — | — | EP | disclosed |
| US-20150298387-A1 | RESIN FOR NANOIMPRINTING, LAMINATE CONTAINING RESIN FOR NANOIMPRINTING, PRINTED BOARD CONTAINING RESIN FOR NANOIMPRINTING, AND METHOD FOR PRODUCING NANOIMPRINT SUBSTRATE | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2015-10-22 | — | — | US | disclosed |
| US-20150203454-A1 | ANTIFUNGAL COMPOUND | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-07-23 | — | — | US | disclosed |
| WO-2015067450-A1 | CATALYTIC HYDROGENATION FOR PRODUCING AMINES FROM CARBOXYLIC ACID AMIDES, CARBOXYLIC ACID DIAMIDES, DI-, TRI-, OR POLYPEPETIDES, OR PEPTIDE AMIDES | EVONIK INDUSTRIES AG (DE) | 2015-05-14 | — | — | WO | disclosed |
| WO-2014025314-A1 | An Antifungal Compound | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2014-02-13 | — | — | WO | disclosed |
| EP-2326175-A2 | ALLOSTERIC ENHANCERS OF THE A1 ADENOSINE RECEPTOR | King Pharmaceuticals Research and Development Inc. (US) | 2011-06-01 | — | — | EP | disclosed |
| WO-2009137782-A2 | ALLOSTERIC ENHANCERS OF THE A1 ADENOSINE RECEPTOR | KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC. (US) | 2009-11-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10937972-B2 | Complex and perovskite material, and perovskite-type solar cell using complex or perovskite material | CRY1, CCNB1, PKN2 | SIGMAR1 959/4885NR1I2 939/4885HTR2A 2380/4885 |
| US-20150203454-A1 | ANTIFUNGAL COMPOUND | ERG28, DPM1, BAK1 | SIGMAR1 4346/4885NR1I2 2814/4885HTR2A 3860/4885 |
| US-11066431-B2 | Complex and method for producing same | SNX9, SCN9A, SNX1 | SIGMAR1 1623/4885NR1I2 1694/4885HTR2A 3554/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.